SEC Form 4 · accession 0000908662-15-000265
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathalie Adda
Officer — Sr. VP & Chief Medical Officer
Period of report
Jun 29, 2015
Accepted (ET)
Jul 1, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $43.46 | Jun 29, 2015 | A | 90,000 | A | — | Jun 29, 2025 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the shares subject to such option will become exercisable on June 29, 2016 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years after the Anniversary Date.